African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin
Domain:
healthcareRecord type:
paper
Creator:
KumJulThiPra
Publisher:
Spr
Host:
Abstract A variant at amino acid 47 in human TP53 exists predominantly in individuals of African descent. P47S human and mouse cells show increased cancer risk due to defective ferroptosis. Here, we show that this ferroptotic defect causes iron accumulation in P47S macrophages. This high iron content alters macrophage cytokine profiles, leads to higher arginase level and activity, and decreased nitric oxide synthase activity. This leads to more productive intracellular bacterial infections but is protective against malarial toxin hemozoin. Proteomics of macrophages reveal decreased liver X receptor (LXR) activation, inflammation and antibacterial defense in P47S macrophages. Both iron chelators and LXR agonists improve the response of P47S mice to bacterial infection. African Americans with elevated saturated transferrin and serum ferritin show higher prevalence of the P47S variant (OR = 1.68 (95%CI 1.07–2.65) p = 0.023), suggestive of its role in iron accumulation in humans. This altered macrophage phenotype may confer an advantage in malaria-endemic sub-Saharan Africa.
Similar
A Personalized Therapeutic Approach for Liver Cancers Expressing the African-Centric P47S Variant of
<i>TP53</i>Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria riskLinking cerebral malaria pathogenesis to APOE-mediated amyloidosisApolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out miceReplication Data for: Iron Status and Associated Malaria Risk Among African ChildrenPan-African hybridization of PfSPZ increases antigenic diversity and replicative capacity for malaria vaccine design